Use of Ribavirin and Low Dose Ara-C to Treat Acute Myeloid Leukemia

Clinical trial NCT01056523 · COMPLETED

Trial details

NCT number: NCT01056523
Sponsor: Jewish General Hospital
Status: COMPLETED
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Acute Myeloid Leukemia

Start date: 2010-01-01
Primary completion: 2015-01-01
Enrollment: 29

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.